Turkmenistan Medical Device Registration: ISO 13485 and Production Conditions Evidence

1. Key takeaways

The requirement for quality system evidence in Turkmenistan can be summarized as three categories, any of which may be chosen, with more being better:

• A certificate of conformity or a declaration of conformity for the production conditions and the product quality requirements;
• A certificate that the production conditions comply with ISO standard requirements;
• A national certificate for the quality control (management) system of medical device production.

In operational terms, the ISO 13485 certificate plus a description of production conditions is the most common combination. The formula works because it covers both halves of what the reviewer wants to see: an independent attestation that a recognized management system governs the site, and a first-party explanation of how the device is actually made. Neither half alone is as convincing as the pair together, and companies that submit only a bare certificate often receive follow-up questions that a two-page production description would have answered in advance.

2. Legal basis

Law No. 319-V of January 12, 2016 sets the general documentation duty, the registration Regulation contains the operative list of quality system evidence, and the Law on Certification supplies the national certification framework under which conformity assessment operates. Reading the three together clarifies why several different document types can satisfy the same dossier item: the regulation defines the evidentiary function, while the certification law defines the attestation bodies.

3. Expert insights

Insight 1: the list uses the words characterizing the conditions of production, which means describe how you manufacture.

The wording of the dossier item is documents that describe the conditions of production and certify that the device complies with the requirements of national or international normative documents. This tells us that what the reviewer wants to understand is under what conditions the product is made, and not merely whether a certificate exists. A description of production conditions, covering a brief process flow, key operations and the cleanliness class, is valuable supporting material. Companies that treat this item as an opportunity rather than a formality typically see fewer questions about the manufacturing site, because the description pre-empts the most obvious lines of enquiry.

Insight 2: ISO 13485 is one accepted form of evidence, but not the only form.

The list places the certificate of production conditions conforming to ISO standard requirements side by side with the national quality system certificate, which shows that Turkmenistan recognizes multiple systems. For Chinese companies, ISO 13485 is the most universal single document; where NMPA quality system verification records exist, they can also serve as supplementary evidence. The breadth of the list is an advantage for applicants with diverse portfolios, because it allows each manufacturer site to submit the strongest attestation it actually holds rather than forcing a single standard worldwide.

Insight 3: the role of the GMP certificate on the device side differs from its role on the drug side.

In the regulatory wording, the GMP certificate is listed among the documents that must be submitted as originals or legalized copies, with Russian translations attached. On the device side, however, ISO 13485 is the more frequently cited document. The practical recommendation is: if GMP-type documents exist, submit them as a supplement, but do not substitute GMP for ISO 13485. The two attestations answer different questions, and a device file anchored on GMP alone invites a deficiency letter that the ISO certificate would have avoided.

Insight 4: site inspections are usually not performed, but this does not mean the system evidence can be thinned.

As explained in article 03, an on-site inspection of the manufacturer is usually not a required procedure, but whether it is performed is at the discretion of the competent authority. Therefore the quality system documentation must be complete. Once the discretion is exercised, the evidence is sitting in the dossier waiting to be examined. A file that looks adequate on paper but would not survive an inspection creates exposure precisely when the authority chooses to look, so the preparation standard should assume that the file may be read closely at any time.

Insight 5: the scope of the certificate must cover the product being applied for.

The site address and the certification scope (product categories) on the ISO 13485 certificate must correspond to the product under application. A certificate whose scope names general medical devices while the application concerns an active device, or whose site address does not match the application form, will be corrected on request. Checking scope before submission is a five-minute task; discovering the mismatch after submission costs a correction cycle and reviewer goodwill alike.

4. Practical recommendations

1. Use the ISO 13485 certificate plus a description of production conditions as the baseline combination.
2. Cover the process flow, key operations and cleanliness class in the production description, proactively explaining how the product is made.
3. Check the site address and certification scope of the certificate so that they match the application form word for word.
4. Submit GMP-type documents as supplements, and never as replacements for ISO 13485.
5. Prepare the quality system documentation to the standard of a possible site inspection, without thinning it.

5. Verification checklist

• □ The ISO 13485 certificate and the production conditions description have been prepared.
• □ The production description includes the process flow, key operations and cleanliness class.
• □ The site address and certification scope of the certificate match the application form.
• □ GMP-type documents have been submitted as a supplement.
• □ The quality system documentation has been assembled to the standard of a possible site inspection.

Regulatory information verified as of October 30, 2026. The content of this document was checked against Law No. 319-V on the Supply of Medicines (January 12, 2016) and the Regulation on National Registration of Medicines and Medical Devices approved by the Ministry of Health (the list of documents describing production conditions and certifying compliance with national or international normative documents); the statement that site inspections are usually not performed but remain within the authority’s discretion comes from the consistent description of current practice and is handled as a practical estimate.

• Local resources in Turkmenistan: GRZAN can coordinate licensed local import entities and authorized representative resources, covering national registration submission, the consular legalization chain for documents, sample delivery, interfaces with mandatory TDS certification, and customs clearance support.
• Service scope: classification determination, selection of the registration pathway, preparation of national-format dossiers, consular legalization and notarization, preparation of testing and stability documentation, organization of GMP and ISO 13485 evidence, changes and renewal, vigilance and post-market maintenance.
• Contact: GRZAN supports manufacturers, importers and authorized representatives with registration in this country; reach us at info@grzanglobal.com.